There is a robust evidence base that antipsychotic medications can improve symptoms and functioning in people with psychotic illnesses. However, nearly all of these medications may have neurological and/or metabolic side effects. Current guidelines discourage antipsychotic polypharmacy, and doses of psychiatric medications outside of recommended ranges may worsen side effects without improving underlying psychiatric symptoms. Strategies for addressing side effects include:
Buchanan, R. W., Kreyenbuhl, J., Kelly, D. L., Noel, J. M., Boggs, D. L., Fischer, B. A, Keller, W. (2010). The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophrenia Bulletin, 36(1), 71-93. doi: 10.1093/schbul/sbp116.
https://www.ncbi.nlm.nih.gov/pubmed/19955390
Goff, D.C., Falkai, P., Fleischhacker, W.W., Girgis, R.R., Kahn, R.M., Uchida, H., Zhao, J., Lieberman, J.A. (2017). The Long-Term Effects of Antipsychotic Medication on Clinical Course in Schizophrenia. Am J Psychiatry, 174(9), 840-849. doi: 10.1176/appi.ajp.2017.16091016. Epub 2017 May 5.
https://www.ncbi.nlm.nih.gov/pubmed/28472900
Takeuchi, H., Kantor, N., Uchida, H., Suzuki, T., Remington, G. (2017). Immediate vs Gradual Discontinuation in Antipsychotic Switching: A Systematic Review and Meta-analysis. Schizophr Bull, 43(4), 862-871. doi: 10.1093/schbul/sbw171. https://www.ncbi.nlm.nih.gov/pubmed/28044008